Arteriosclerosis, Thrombosis, and Vascular Biology

Show Articles
Journal Properties
  • Formerly known as
    Arteriosclerosis and Thrombosis
  • Country
    United States
  • Language
    English
  • Number of Articles
    15,384
  • Abbreviation
    Arterioscler, Thromb, Vasc Biol
  • ISSN
    1079-5642
  • e-ISSN
    1524-4636
  • Main Publisher
    Wolters Kluwer Health
  • Publisher
    Ovid Technologies (Wolters Kluwer Health)
  • Indian UGC
  • Indian UGC Name
  • DOAJ (latest)
Journal Properties
  • Medicine
    Internal medicine
    Specialties of internal medicine
    Diseases of the blood and blood-forming organs
    Medicine
    Internal medicine
    Specialties of internal medicine
    Diseases of the circulatory (Cardiovascular) system
    Medicine
    Medicine (General)
  • website
Description
This journal is a top-tier publication dedicated to advancing the understanding and treatment of cardiovascular diseases. It focuses on arteriosclerosis, thrombosis, and vascular biology. Arteriosclerosis, Thrombosis, and Vascular Biology disseminates cutting-edge research in basic, translational, and clinical science. It covers topics including lipid metabolism, inflammation, thrombosis, angiogenesis, and vascular cell biology. The journal welcomes original research articles, reviews, and perspectives that contribute to unraveling the complexities of vascular diseases. Indexed in leading databases like PubMed, Web of Science, and Scopus. The Arteriosclerosis, Thrombosis, and Vascular Biology plays a critical role in shaping the future of cardiovascular medicine and improving patient outcomes. Consider submitting your research to this prestigious journal to connect with a global network of experts and contribute to the advancement of vascular biology.